MedTrace Logo

Survival Outcomes of Uterine Malignancies in Chinese Population

NCT03291275 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2018-02-08

No results posted yet for this study

Summary

This study aims to determine survival outcomes (overall survival and progression-free survival) of primary uterine malignancies in China and relevant risk factors in a prospective cohort study.

Conditions

  • Endometrial Neoplasms
  • Survival

Interventions

OTHER

Follow-up for death and recurrence

All patients are followed up to determine definite date of diagnosis, recurrence and death.

Sponsors & Collaborators

  • Lei Li

    lead OTHER

Principal Investigators

  • Lei Li, MD · Peking Union Medical College Hospital

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-01
Primary Completion
2022-09-01
Completion
2023-09-01

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03291275 on ClinicalTrials.gov